Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Agnese Miranda
Observed names:
A Miranda,
A. Miranda
Institutions:
University of Campania "Luigi Vanvitelli",
Ospedale Monaldi
Observed institutions:
University of Campania "Luigi Vanvitelli",
Federico II University Hospital,
Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli,
Ospedale Monaldi
ORCID:
0000-0003-4682-9087
Observed ORCID:
0000-0003-4682-9087
OpenAlex ID:
A5033161677
Pyoderma gangrenosum: an updated review
2009
·
E Ruocco
, S Sangiuliano
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
529
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
·
Javier Molina–Infante
, Marco Romano
, et al.
·
Gastroenterology
·
315
PDF
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
2010
·
Marco Romano
, Antonio Cuomo
, et al.
·
Gut
·
159
Extra-Gastric Manifestations of Helicobacter pylori Infection
2020
·
Antonietta G. Gravina
, Kateryna Priadko
, et al.
·
Journal of Clinical Medicine
·
123
PDF
Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments
2015
·
J. P. Gisbert
, M. Romano
, et al.
·
Alimentary Pharmacology & Therapeutics
·
122
PDF
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea
2014
·
AG Gravina
, A Federico
, et al.
·
United European Gastroenterology Journal
·
101
PDF
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
2009
·
Rita Cariello
, Alessandro Federico
, et al.
·
Digestive and Liver Disease
·
95
Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease
2012
·
Anna Del Prete
, Antonella Scalera
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
93
PDF
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
·
Alessandro Federico
, Gerardo Nardone
, et al.
·
Gastroenterology
·
92
The Role of Stress in Inflammatory Bowel Diseases
2017
·
Dolores Sgambato
, Agnese Miranda
, et al.
·
Current Pharmaceutical Design
·
89
Bone alterations in inflammatory bowel diseases
2019
·
Dolores Sgambato
, Francesca Gimigliano
, et al.
·
World Journal of Clinical Cases
·
67
PDF
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
2022
·
Sara Onali
, Daniela Pugliese
, et al.
·
The American Journal of Gastroenterology
·
57
Gut microbiota and gastric disease
2017
·
Dolores Sgambato
, Agnese Miranda
, et al.
·
Minerva Gastroenterology
·
45
Prevalence of Helicobacter pylori infection in sexual partners of H. pylori‐infected subjects: Role of gastroesophageal reflux
2018
·
Dolores Sgambato
, Giulio Visciola
, et al.
·
United European Gastroenterology Journal
·
41
PDF
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
2021
·
Michele Francesco Chiappetta
, Anna Viola
, et al.
·
Expert Opinion on Biological Therapy
·
40
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study
2015
·
Gianluca Rotondano
, Antonio Rispo
, et al.
·
Digestive and Liver Disease
·
36
The burden of anaemia in patients with inflammatory bowel diseases
2015
·
Anna Testa
, Antonio Rispo
, et al.
·
Digestive and Liver Disease
·
35
Non‐bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real‐life study
2020
·
Marco Romano
, Antonietta Gerarda Gravina
, et al.
·
Helicobacter
·
34
Gut-Brain Axis in Gastric Mucosal Damage and Protection
2016
·
Dolores Sgambato
, Annalisa Capuano
, et al.
·
Current Neuropharmacology
·
33
PDF
Efficacy of ustekinumab in the treatment of patients with Crohn's disease with failure to previous conventional or biologic therapy: a prospective observational real-life study.
2021
·
A Miranda
, A G Gravina
, et al.
·
PubMed
·
30
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
2014
·
Javier P. Gisbert
, Marco Romano
, et al.
·
Digestive and Liver Disease
·
29
Inflammatory Bowel Diseases: The Role of Gut Microbiota
2020
·
Cristiana De Musis
, Lucia Granata
, et al.
·
Current Pharmaceutical Design
·
28
Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study
2023
·
Lorenzo Romano
, Raffaele Pellegrino
, et al.
·
Digestive and Liver Disease
·
23
Crohn’s disease and skin
2015
·
AG Gravina
, A Federico
, et al.
·
United European Gastroenterology Journal
·
23
PDF
Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms
2024
·
Lorenzo Romano
, Luigi Napolitano
, et al.
·
The Prostate
·
22
Show more works
View as search
Works count:
78
Citation count:
2,411
H-index:
23
I10-index:
31
Year
Topic
Type